📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge. (2015)

First Author: Calvo-Pinilla E

Attributed to: Expression and formulation of bluetongue virus genes and proteins for development of effective vaccination strategies. THIS GRANT IS A SUPPLEMENTATION funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.antiviral.2015.01.009

PubMed Identifier: 25643968

Publication URI: http://europepmc.org/abstract/MED/25643968

Type: Journal Article/Review

Volume: 116

Parent Publication: Antiviral research

ISSN: 0166-3542